Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,709Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1BRECKENRIDGE PHARMS

02 2AJANTA PHARMA LTD

03 2ANNORA PHARMA PRIVATE LIMITED

04 1AUROBINDO PHARMA LIMITED

05 1AUROBINDO PHARMA LTD

06 2DEXCEL

07 1HIKMA

08 1MICRO LABS

09 2MSN PHARMS INC

10 2PF PRISM CV

11 3PFIZER

12 1PRINSTON PHARMA INC

13 2YAOPHARMA CO LTD

14 3ZYDUS PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Approval Date : 2021-06-01

Application Number : 212943

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Approval Date : 2023-03-13

Application Number : 209738

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Approval Date : 2012-11-06

Application Number : 203214

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Approval Date : 2018-05-30

Application Number : 203214

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 11MG BASE

Approval Date : 2016-02-23

Application Number : 208246

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 22MG BASE

Approval Date : 2019-12-12

Application Number : 208246

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 1MG BASE/ML

Approval Date : 2020-09-25

Application Number : 213082

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TOFACITINIB

Brand Name : TOFACITINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Approval Date :

Application Number : 209923

RX/OTC/DISCN :

RLD :

TE Code :

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Approval Date : 2023-03-13

Application Number : 209829

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank